Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


8 Items
Title  Creator  Group name  Publishing year 
A Comprehensive Analysis of the Dynamic Response to Aphidicolin-Mediated Replication Stress Uncovers Targets for ATM and ATMIN Mazouzi et al. EquipeJC Apr 14 2016
The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity Heinz et al. EquipeJC Jun 30 2015
Targeting a cell state common to triple-negative breast cancers Muellner et al. EquipeJC Jan 2015
Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling Huber et al. EquipeJC Nov 2015
Germline RBBP6 mutations in familial myeloproliferative neoplasms Harutyunyan et al. EquipeJC Nov 16 2015
A surface biotinylation strategy for reproducible plasma membrane protein purification and tracking of genetic and drug-induced alterations Hormann et al. EquipeJC Dec 24 2015
Comprehensive comparative and semiquantitative proteome of a very low number of native and matched epstein-barr-virus-transformed B lymphocytes infiltrating human melanoma Maurer et al. EquipeJC Jun 6 2014
A chemical biology approach identifies AMPK as a modulator of melanoma oncogene MITF Borgdorff et al. EquipeJC May 8 2014
8 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés